Return On Assets of Corvus Pharmaceuticals, Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Corvus Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Corvus Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -20%, a 81% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2024 was -107%, a 112% decline from 2023.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2023 was -51%, a 4.8% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2022 was -48%, a 25% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -20% +89% +81% 01 Jul 2025 30 Sep 2025
Q2 2025 -65% -21% -46% 01 Apr 2025 30 Jun 2025
Q1 2025 -66% -15% -29% 01 Jan 2025 31 Mar 2025
Q4 2024 -107% -57% -112% 01 Oct 2024 31 Dec 2024
Q3 2024 -109% -58% -113% 01 Jul 2024 30 Sep 2024
Q2 2024 -45% +14% +24% 01 Apr 2024 30 Jun 2024
Q1 2024 -51% +4% +7% 01 Jan 2024 31 Mar 2024
Q4 2023 -51% -2% -4.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -51% -9% -20% 01 Jul 2023 30 Sep 2023
Q2 2023 -59% -24% -70% 01 Apr 2023 30 Jun 2023
Q1 2023 -55% -18% -50% 01 Jan 2023 31 Mar 2023
Q4 2022 -48% -10% -25% 01 Oct 2022 31 Dec 2022
Q3 2022 -42% -36% -575% 01 Jul 2022 30 Sep 2022
Q2 2022 -35% -28% -439% 01 Apr 2022 30 Jun 2022
Q1 2022 -36% -30% -517% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% -30% -350% 01 Oct 2021 31 Dec 2021
Q3 2021 -6% +58% +90% 01 Jul 2021 30 Sep 2021
Q2 2021 -6% +52% +89% 01 Apr 2021 30 Jun 2021
Q1 2021 -6% +48% +89% 01 Jan 2021 31 Mar 2021
Q4 2020 -9% +39% +82% 01 Oct 2020 31 Dec 2020
Q3 2020 -64% -21% -48% 01 Jul 2020 30 Sep 2020
Q2 2020 -58% -18% -47% 01 Apr 2020 30 Jun 2020
Q1 2020 -54% -19% -52% 01 Jan 2020 31 Mar 2020
Q4 2019 -48% -12% -35% 01 Oct 2019 31 Dec 2019
Q3 2019 -43% -5% -14% 01 Jul 2019 30 Sep 2019
Q2 2019 -40% +2% +4.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -36% +11% +23% 01 Jan 2019 31 Mar 2019
Q4 2018 -35% +15% +30% 01 Oct 2018 31 Dec 2018
Q3 2018 -38% +7% +15% 01 Jul 2018 30 Sep 2018
Q2 2018 -42% -2% -5.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -47% -14% -45% 01 Jan 2018 31 Mar 2018
Q4 2017 -50% -26% -109% 01 Oct 2017 31 Dec 2017
Q3 2017 -45% -23% -102% 01 Jul 2017 30 Sep 2017
Q2 2017 -39% 01 Apr 2017 30 Jun 2017
Q1 2017 -32% 01 Jan 2017 31 Mar 2017
Q4 2016 -24% 01 Oct 2016 31 Dec 2016
Q3 2016 -22% 01 Jul 2016 30 Sep 2016

Corvus Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -107% -57% -112% 01 Jan 2024 31 Dec 2024
2023 -51% -2% -4.8% 01 Jan 2023 31 Dec 2023
2022 -48% -10% -25% 01 Jan 2022 31 Dec 2022
2021 -39% -30% -350% 01 Jan 2021 31 Dec 2021
2020 -9% +39% +82% 01 Jan 2020 31 Dec 2020
2019 -48% -12% -35% 01 Jan 2019 31 Dec 2019
2018 -35% +15% +30% 01 Jan 2018 31 Dec 2018
2017 -50% -26% -109% 01 Jan 2017 31 Dec 2017
2016 -24% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.